9 Reviews
I absolutely love Rapt! Their products are always great and the customer service is excellent. 😄
I love shopping at Rapt! Their products are amazing and the customer service is top-notch. 😊
Rapt has a wide selection of great products. The website is user-friendly and the pricing is reasonable. I had a positive experience shopping with them.
The products I received from this company were fantastic. Everything was of high quality and exactly as described. I'm extremely satisfied with my purchase.
The products I purchased from Rapt were awesome. The quality exceeded my expectations and the website was very user-friendly. I would highly recommend them.
I enjoy shopping at Rapt. The website is easy to navigate and they offer a good selection of products. 👍
I had a really great experience with Rapt. The customer service was excellent and the website was easy to navigate. I would highly recommend them to anyone looking for quality products.
Their products are fantastic. The quality is amazing and the prices are reasonable. I had a great shopping experience with them.
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Rapt
RAPT Therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases. In its first four years since inception, RAPT has discovered and advanced two unique drug candidates, each targeting C-C motif chemokine receptor 4. The company’s lead oncology drug candidate, FLX475, reached the clinic in just two and a half years with its lead inflammation drug candidate, RPT193, also in the clinic. The company is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1, that are in the discovery stage of development.
- Website
- rapt.com
- [email protected]
- Address
- 561 eccles avenue
- Categories
- Computer software
